Kestra Advisory Services, LLC Acelrx Pharmaceuticals Inc Transaction History

Kestra Advisory Services, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$1.25 - $2.77 $16,000 - $35,456	-12,800 Closed	0 $0
Q4 2020 Jan 20, 2021	BUY	$1.18 - $1.98 $1,298 - $2,178	1,100 Added 9.4%	12,800 $16 Million
Q3 2020 Nov 12, 2020	BUY	$1.01 - $1.81 $11,817 - $21,177	11,700 New	11,700 $17 Million

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.